INTRODUCTION
Morphine and its derivatives act as powerful analgesics, but also induce profound tolerance and dependence, limiting clinical use of opioids (Martin and Fraser, 1961) . Although both beneficial and detrimental effects are triggered by activation of m-opioid receptors, they are believed to be mediated by different signaling pathways. The analgesic effects are predominantly associated with activation of Gi, the inhibitory G protein for adenylyl cyclase (Raffa et al., 1994) . At the same time, activation of OPRMs leads to their phosphorylation and subsequent b-arrestin binding, thus resulting in termination of GPCR signals (Luttrell and Lefkowitz, 2002) . Moreover, OPRMs are known to desensitize quickly upon activation by opioids (Kenski et al., 2005; Schulz et al., 2004) , which complicates understanding of sustained analgesic effects and withdrawal syndrome. Unraveling the pathways underlying sustained opioid responses and withdrawal syndrome will enable development of more effective and safer drugs.
Distorted thermal sensation is one of the various sensory responses modulated by opiate application. Patients frequently describe waves of warmth upon drug administration, as well as cold chills often in combination with hyperalgesia during withdrawal, whereas supporting in vivo observations demonstrate elevated responsivity in cold-pressor tests (Chu et al., 2006; Pud et al., 2006; Ren et al., 2009) . Recently, TRPM8 has been shown to be responsible for mild cold sensation in animals (Bautista et al., 2007) . General in vivo observations revealed that opioids suppress icilin-induced wet-dog shaking (Werkheiser et al., 2006) and lead to hyperthermia (Rawls and Benamar, 2011) . However, molecular mechanisms that would successfully explain such observations are lacking. Here, we present evidence for a mechanism regulating thermosensation in response to chronic OPRM stimulation. Activation of OPRM1 leads to internalization of a cold-sensor TRPM8, causing cold analgesia in mice and can be reversed by a follow-up treatment with inverse OPRM agonist naloxone. Knockout of TRPM8 protein, in turn, leads to a decrease in morphine-induced cold analgesia. The proposed pathway represents a universal mechanism that is likely shared by regulatory pathways modulating general pain sensation in response to opioid treatment.
RESULTS

Stimulation of OPRM1 Suppresses TRPM8 Activity in Dorsal Root Ganglion Neurons
To address the issue of abnormal opiate-related thermosensation, we examined whether TRPM8 activity can be regulated by OPRM1 in the subpopulation of native rat sensory dorsal root ganglion (DRG) neurons, mediating cold sensation (e.g., Craig, 2002) . Studies were carried out on the subset of small diameter DRG neurons that exhibited menthol-induced I TRPM8 with its characteristic biphysical properties (McKemy et al., 2002) . Figure 1A compares currents evoked by 100 mM menthol in the absence and in the presence of 10 mM morphine. As can be seen, application of morphine caused a slow reduction of menthol-evoked current in DRG neurons that, within 10 min, led to small but significant decrease of the mean I TRPM8 at the membrane potential of +100 mV ( Figure 1B ) that provided the best signal-to-noise ratio, as well as at a more physiological À60 mV (Figures S1A and S1B) . Moreover, application of 10 mM naloxone, following this morphine treatment, led to similarly slow restoration of the I TRPM8 to the original levels, as demonstrated in Figures 1A and 1B . Compared are currents in control cells (white circles), cells that were treated with 10 mM morphine (gray triangles), and cells where morphine treatment was followed by application of 10 mM naloxone (filled squares). Traces were normalized to their peaks at the time of menthol application. (B) Bar plot summarizes the responses to menthol in control, morphine, and morphine followed by naloxone-treated cells (n = 8, 6, and 4). Statistical analysis was performed for the amplitude of the currents recorded at a time indicated by vertical arrow in (A). (C) Sample activity of TRPM8 in excised outsideout patches. Measurement of basal activity (left) was followed by application of 10 mM morphine (middle) for an extended duration (typically 10 min) and, finally, of menthol (right) to verify the identity of the recorded single ion channels. (D) Bar plot comparing average activity in outsideout patches in response to morphine and menthol, normalized to basal activity level in each trace (n = 8).
(E) Sample activity of TRPM8 in cell-attached patches to DRG neurons shows characteristic voltage dependence of the channel. *p < 0.05 and **p < 0.01. Data are presented as mean ± SEM. See also Figure S1 .
In order to check how TRPM8 gating has been altered by morphine, we studied the currents in cell-attached patches made to DRG neurons. These patches exhibited currents, characteristic of TRPM8 channel (Ferná ndez et al., 2011) (Figure 1E ). However, majority of the patches from TRPM8-expressing DRG neurons exhibited multiple conductance levels, thus precluding true single-channel analysis of TRPM8 kinetics. This limited our analysis to characterization of overall probability of TRPM8 opening (NP open ), which depends on both the channel-gating properties and the number of active TRPM8 channels within the patch. The NP open measurements were carried out in excised outsideout patches and compared basal TRPM8 activity with that in morphine before and after menthol application. Figure 1C illustrates typical single-channel currents observed in these patches, and Figure 1D summarizes the average NP open in the corresponding regions of the acquired patches, normalized to basal activity in each patch. Figure S1C shows effect of morphine on menthol-induced TRPM8 currents, and Figure S1D summarizes NP open values, normalized to menthol-stimulated activity before morphine application. Similarly to whole-cell currents, morphine treatment caused a slow ($15% in 10 min) but significant reduction of overall TRPM8 activity.
To determine if there is any functional consequence of morphine-dependent suppression of TRPM8 activity, we related spontaneous ( Figure 2A ) and menthol-induced ( Figure 2B ) (middle) detected with confocal imaging of fluo-3 fluorescence. Self-normalized (F/F 0 ) images (bottom) were captured during the periods highlighted on the plots (middle) by gray background (i and ii, respectively). Imaging was performed at 20 Hz (A) and 60 Hz (B). Note that Ca 2+ spikes initiated in subplasmalemmal regions.
(C) Menthol-induced [Ca 2+ ] i changes in DRG neurons with depleted Ca 2+ stores (1 hr incubation with 50 mM of cyclopiazonic acid) were monitored using x-y imaging (at 0.6 Hz) of fluo-4 fluorescence. The fluorescence intensity (F) was normalized to the averaged fluorescence intensity before menthol application (F 0 ). The traces (DF/F 0 ) were obtained in control (top), after 2 hr incubation with 10 mM morphine (middle) and following 2 hr incubation with 10 mM naloxone after 2 hr morphine pretreatment (bottom). The galleries below the plots demonstrate the images captured at 2 min interval.
(D) Bar-diagram plot compares masses of the fluo-4 signal, R ðDF=F 0 Þ, during first 40 min after menthol application in control (n = 15) and following morphine (n = 21) and naloxone (n = 17) treatment. ***p < 0.001. Data are presented as mean ± SD. changes in the cell membrane potential to the changes of [Ca 2+ ] i in DRG neurons and then examined the effects of 2 hr incubation with 10 mM morphine and 2 hr incubation with 10 mM naloxone after 2 hr morphine pretreatment on menthol-induced [Ca 2+ ] i changes in DRG neurons with depleted Ca 2+ stores ( Figures   2C and 2D ). This revealed that spontaneous action potentials (APs) are associated with Ca 2+ spikes initiated at subplamalemmal regions and reflecting Ca 2+ entry into the cell (Figure 2A ). Application of 100 mM menthol caused membrane depolarization, which was associated with increased frequency of APs. ] i response was virtually completely abolished after 2 hr incubation with 10 mM morphine ( Figure 2C , middle) but was recovered following 2 hr incubation with 10 mM naloxone ( Figure 2C , bottom). The temporal pattern of the menthol-induced [Ca 2+ ] i response was complex and was affected by morphine pretreatment. To quantify the effects we used the ''signal mass'' approach, developed previously to determine the Ca 2+ fluxes underlying localized [Ca 2+ ] i transients in smooth muscle cells (Amberg et al., 2007; Zou et al., 2004) . We compared integrals of the fluo-4 signal (averaged within confocal optical slice of the cell) during the first 40 min after menthol application in control, and following morphine and naloxone treatment ( Figure 2D ). This revealed that TRPM8-linked Ca 2+ entry is significantly (p < 0.001) suppressed by morphine but is restored by naloxone.
Morphine Suppresses Heterologous TRPM8 Activity in HEK293 Cells
Having established that stimulation of OPRM1 leads to gradual decrease of TRPM8 activity in sensory neurons, we utilized a controlled expression system to study the mechanisms underlying this regulation. HEK293 cells stably expressing human TRPM8 (HEK293 M8 ) were cultured as described previously (Thebault et al., 2005) and were transfected with OPRM1 plasmid. The cells were then pretreated with 10 mM morphine for 40 min or left untreated. Cold (20 C) or menthol (100 mM) -induced TRPM8 activity was recorded as shown in Figure 3B . Morphine pretreatment significantly inhibited both cold-and mentholinduced TRPM8 currents ( Figures 3C and 3D, respectively) . This inhibition, however, was not observed in the cells that did not express OPRM1 ( Figures S2A and S2B ), indicating that effect of morphine on I TRPM8 is mediated by OPRM1. Moreover, suppression of TRPM8 currents by morphine could be reversed by follow-up treatment with an inverse agonist of OPRM, naloxone (10 mM). Cells incubated for 1 hr with naloxone after or without morphine pretreatment revealed slightly, but significantly, bigger TRPM8 currents than those observed in control cells ( Figures 3C  and 3D) . Additionally, the effect of morphine could be blocked by a G protein inhibitor pertussis toxin (PTX), as shown in Figures  3B-3D . Interestingly, morphine treatment did not change relative potency of menthol versus cold to activate TRPM8 currents (Figure S2C) , suggesting that the mechanism suppressing TRPM8 activity is insensitive to the mode of TRPM8 stimulation.
To ensure physiological relevance of the measured changes in TRPM8 currents caused by morphine or naloxone, we investigated whether TRPM8 activity suppression leads to detectable changes in intracellular Ca 2+ concentration. OPRM1-transfected HEK293 M8 cells were loaded with fura-2 and analyzed as described previously (Thebault et al., 2005) . Incubation with morphine significantly inhibited TRPM8-mediated Ca 2+ entry, whereas subsequent naloxone treatment restored it to the levels above control (Figures 3E and 3F) , in agreement with electrophysiological observations.
Single-Channel Kinetics of TRPM8 Is Unaffected by OPRM1 Activation Activation of OPRM1 can suppress TRPM8 activity by modulating either channel-gating properties or expression and/or localization of TRPM8 protein. To verify the mechanism of OPRM1-TRPM8 interaction, each of the two possibilities were explored.
To investigate whether OPRM1 affects the TRPM8 channel gating, we analyzed single-channel activity in HEK293 cells expressing TRPM8 under the control of tetracycline-inducible promoter (Thebault et al., 2005) and transfected with OPRM1, as described above. The TRPM8 channel activity became detectable in cell-attached patches within $4.3 hr of induction of TRPM8 expression by tetracycline. To limit TRPM8 expression to one channel per patch (see Figure S3 for sample of TRPM8 channel activity at various membrane potentials), the currents were recorded within 30 min of observation of initial TRPM8 activity. Interestingly, this yielded results different from the patches containing multiple TRPM8 channels (DRG neurons, above), where whole-cell currents or NP open values in outsideout patches were clearly decreased by morphine. Now, no discernible difference either in the current trace features or in the generated all point histograms (Figures 4A and 4B) was seen. Kinetic analysis of these data, carried out following the procedures described earlier (Ferná ndez et al., 2011) , also revealed no difference in the distributions of closed and open dwell times ( Figure 4C ) or in the established kinetic models and P open ( Figures 4D-4F ). Thus, suppression of the TRPM8 currents observed in the whole-cell or multiple-channel patch-clamp recordings following OPRM1 activation is not caused by the modulation of the channel-gating kinetics.
Colocalization and Internalization of OPRM1 and TRPM8 Proteins Activation of OPRM1 leads to its phosphorylation, recruitment of b-arrestins, and internalization of the receptor. Moreover, OPRM regulation is known to be agonist specific, so that regulatory events recruited by morphine differ from those induced by other opioids (Burford et al., 1998; McPherson et al., 2010) . In particular, it was recently shown that morphine promotes interaction of OPRM1 only with b-arrestin2 and not b-arrestin1 (Groer et al., 2007 (Groer et al., , 2011 Li et al., 2009) and that this interaction is sufficient to induce OPRM1 internalization, but not receptor ubiquitination and subsequent degradation (Groer et al., 2011) .
To check whether these features of OPRM1 regulation can account for the observed suppression of TRPM8 current by morphine, we examined the possibility of direct interaction between the two proteins and their plasmalemmal trafficking. Coupling between OPRM1 and TRPM8 was tested using immunoprecipitation performed on HEK293 cells transfected with Histagged TRPM8 with or without OPRM1. Cell extracts were first immunoprecipitated with His antibody, and the precipitated proteins were analyzed by immunoblotting for OPRM1. ORPM1 was present on the beads and was detected in the precipitated complex (IP) with TRPM8 when both proteins were cotransfected. Only a weak band was detected on precipitated complex from the cells not transfected with ORPM1 ( Figure 5A ). Regulation of the TRPM8 plasmalemmal trafficking by morphine was assessed with biotin labeling. HEK293 M8 cells were transfected with OPRM1 receptor plasmid as described previously and treated with 10 mM morphine for 0, 10, and 40 min. Subsequent cell-surface biotinylation showed that morphine treatment led to a progressive removal of TRPM8 from plasma membrane in the cells expressing OPRM1 but not in the cells expressing TRPM8 alone ( Figure 5B ). Prolonged morphine treatment only increased removal of TRPM8 channel from the membrane, whereas subsequent application of 10 mM naloxone for 1 hr was sufficient to revert internalization of the channel and permitted TRPM8 to reach the cell surface again ( Figure 5C ).
The results of the biotinylation and electrophysiological experiments were further confirmed by direct visualization of cellular distribution of immunostained TRPM8 and OPRM1 proteins in DRG neurons using fluorescence confocal imaging ( Figure 5D ). In these experiments, primary antibody-specific binding to TRPM8 and OPRM1 was visualized with Alexa-Fluor-488-conjugated immunoglobulin (Ig) G and Rhodamine-Red-X-conjugated IgG, respectively. Immunostaining was performed in control conditions and following 12 hr incubation with 10 mM morphine. This revealed that spatial pattern of the fluorescence signal of both fluorophores was altered following morphine treatment from peripheral bright outline to more homogeneous cytoplasmic distribution, thus confirming that activation of OPRM1 induces internalization of the both proteins.
To relate predominant peripheral appearance of TRPM8 protein to position of the plasma membrane and to monitor how it is altered after morphine treatment, we extended our study to the model cells where (1) the expression of TRPM8 can be visualized by YFP in living cells and (2) the level of its expression can be controlled. In these experiments, HEK293 cells were cotransfected with TRPM8-YFP and OPRM1 plasmids and were imaged 36 hr later. Figure 6A compares spatial distribution profiles of TRPM8-YFP protein in control cells and cells treated with 10 mM morphine for 24 hr or cells treated with 10 mM naloxone for 3 hr following the 24 hr morphine treatment. The long-term morphine treatment led to redistribution of TRPM8 channel from plasma membrane to cell interior. This was reversed by the follow-up treatment with naloxone. Assessment of the dynamics of the TRPM8 redistribution within 90 min of the drug application revealed a gradual decrease of enhanced yellow fluorescent protein (eYFP) fluorescence at plasma membrane (PM) in response to 10 mM morphine ( Figure 6B ), and progressive relocation of eYFP fluorescence to PM induced by 10 mM naloxone in morphine-pretreated cells ( Figure 6C ).
Knockout of TRPM8 in Mice Suppresses Morphine Antinociceptive Action and Cold Hyperalgesia during Morphine Withdrawal
To analyze whether morphine-dependent trafficking of TRPM8 is related to morphine-induced cold analgesia, we compared the antinociceptive effect of morphine in TRPM8 À/À and control mice using the tail immersion test. In line with a previous report (Bautista et al., 2007) , we observed higher basal withdrawal threshold in TRPM8 À/À mice than in WT animals, confirming the hyposensitivity of these KO animals. Figure 7A shows a significant decrease of morphine-induced cold analgesia in TRPM8 À/À mice at 5 C, 10 C, 15 C, and 20 C. Interestingly, this effect was observed at all tested temperatures, with the reduction of morphine analgesic effect ranging from 40% when the test was carried out at 20 C to 89% when the test was carried out at 10 C. Although TRPM8 serves as an important receptor for cooling sensation (Bautista et al., 2007; Colburn et al., 2007; Dhaka et al., 2007) , a recent study (Pogorzala et al., 2013) reports an important thermal deficit in TRPM8-DTX mice below 15 C, suggesting a potential role of the channel even in noxious cold perception.
Further, we have tested the importance of TRPM8 in the manifestation of the withdrawal syndrome induced by naloxone following a prolonged exposure to morphine ( Figure 7B ). The response was assessed by the number of escape jumps, as a measure of physical dependence ( Figure 7C) , and by the difference in pain thresholds using the cold-plate test, corresponding to morphine-induced hyperalgesia (Chang et al., 2007) (Figure 7D) . Interestingly, the scores were significantly decreased in TRPM8 À/À mice ( Figures 7C and 7D ), indicating that TRPM8 channels are involved in morphine-induced physical dependence and cold hyperalgesia, respectively.
DISCUSSION
In summary, our data demonstrate direct interaction between OPRM1 and TRPM8 proteins and reveal a mechanism underlying the distorted cold sensitivity upon administration of opioids. TRPM8 is regulated by a variety of pathways involving PIP2, iPLA2/LPLs, and G-proteins (Bavencoffe et al., 2011) . Of particular interest are the mechanisms involving activation of various receptors, such as B2R or AChR, and leading to changes in TRPM8 activity without affecting its localization (Bavencoffe et al., 2010; Zhang et al., 2012) . However, unlike these previously reported modulations, the presented mechanism does not affect gating properties of the channel. Instead, activation of OPRM1 leads to internalization of TRPM8 protein that could, at least partially, explain the cold antinociceptive effect of morphine. Initiation of drug withdrawal effect by treating abstinent mice with an OPRM reverse agonist, naloxone, may lead to TRPM8 reconstitution and could be linked to increased TRPM8 activity and associated Ca 2+ entry seen in cell-culture models. Although it is possible that OPRM1 activation may also recruit the regulatory mechanism described previously (Bavencoffe et al., 2011) , here we demonstrated that TRPM8 channels are rapidly internalized following OPRM1 activation. Thus, possible regulation of the TRPM8 channel gating by OPRM1 is of limited physiological significance, leaving the internalization as a primary means responsible for the changes observed in vivo. In addition, such a mechanism allows us to reconcile the observations of rapid OPRM1 desensitization and sustained suppression of cold response. Moreover, with some studies reporting cold-induced hyperalgesia (Wasner et al., 2004) or analgesia (Cliff and Green, 1996) in drug addicts, many studies of pain tolerance in opiate abusers utilizing coldpressor tests (Chu et al., 2006; Compton, 1994; Ren et al., 2009 ) and mounting evidence of correlation between pain responses to different stimuli (Neddermeyer et al., 2008) , it is interesting to speculate that distorted cold and pain sensitivity share at least some signaling pathways. In line with this prospect, the proposed mechanism could provide a basis for understanding changes not only in thermal sensation but also in general analgesia associated with opiate administration and hyperalgesia associated with abstinence.
EXPERIMENTAL PROCEDURES Cell Cultures and Nucleofection
Eight-to twelve-week-old Wistar rats were killed by inhalation of 100% CO 2 , followed by decapitation. Twelve to fifteen DRGs from thoracic and lumbar regions were dissected and incubated at 37 C for 30 min in standard bath solution containing (in mM): 140 NaCl, 5 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 glucose, and 10 HEPES (pH 7.4), supplemented with 2 mg/ml collagenase (type 1A, SigmaAldrich). The ganglia were then transferred to 0.05% trypsin/EDTA into Ca 2+ -and Mg
2+
-free Hank's balanced salt solution for 2 min at 37 C. After incubation, ganglia were washed three times with bath solution, centrifuged at 1,000 rpm for 4 min, and resuspended in 1 ml of medium containing DMEM/Ham's F12, 10% fetal bovine serum, and 1% penicillin/streptomycin. Dissociated cells were obtained by trituration through a fire-polished glass Pasteur pipette, plated on poly-L-lysine (1 mg/ml)-coated Petri dishes (Nunc) with the same medium, and maintained at 37 C in a humidified atmosphere of 5% CO 2 and 95% air before patching. The neurons were used for recordings within next 24 hr. HEK293 M8 cells were cultured, and, where necessary, TRPM8 expression was induced by tetracycline as described previously (Thebault et al., 2005) . For the single-channel studies, the tetracycline repressor-expressing HEK293 cells were used, and the expression of the channel was induced with 1 mg/ml tetracycline for 4.3 hr before use. Cells were used for patch-clamp experiments and cell-surface biotinylation 36-48 hr after nucleofection. For fluorescence imaging, cells were transfected with 2 mg of each construct and 0.2 mg of pmax GFP using Nucleofector (Amaxa). The constructs that have been used are the human TRPM8pcDNA4 (Thebault et al., 2005) , TRPM8 peYFP-C1 (Bidaux et al., 2012) , and my-ORpIREShyg2, which was a kind gift of Professor Michael Xi Zhu (Department of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston Medical School).
Patch-Clamp Recordings and Data analysis
Patch-clamp experiments were performed using Axopatch 200B amplifier and pClamp 10.0 software (Molecular Devices) for data acquisition and analysis. Patch pipettes were fabricated from borosilicate glass capillaries (World Precision Instruments) on horizontal puller (Sutter Instruments) and had resistance of 2-3 MU for the whole-cell and 6-10 MU for single-channel recordings. For the whole-cell patch-clamp recordings, DRG neurons and HEK293 M8 cells were bathed in the standard extracellular solution (in mM): 140 NaCl, 5 KCl, 10 glucose, 10 HEPES, 2 CaCl 2 , and 2 MgCl 2 (pH 7.4). The pipettes were filled with Cs-based intracellular solution to minimize background outward currents, (in mM): 140 CsCl, 5 EGTA, 10 HEPES, pH adjusted to 7.3 with Cs(OH), supplemented by 2 mM Mg-ATP, and 0.5 mM Li-GTP in the case of recordings on DRG neurons.
Single-channel recordings were carried in outside-out patches made to DRG neurons and cell-attached patches to HEK293 M8 cells. Cells were immersed in hi-K solution (in mM: 150 KCl, 5 glucose, 10 HEPES, 1 CaCl 2 , 2 MgCl 2 [pH 7.3], adjusted with KOH) in order to keep membrane potential close to zero. Pipettes were filled with the same KCl solution, to keep recording conditions symmetrical, and supplemented with 100 mM menthol to match wholecell stimulation of TRPM8 and, in case of cell-attached recordings of morphine-suppressed currents in HEK293 M8 cells, with 10 mM morphine.
Recorded activity was quantified by performing a single-channel search analysis using the Clampfit-10 (pClamp software suit, Molecular Devices) and QuB 2.0 programs. Stimulation of TRPM8 by both mild cold and application of 100 mM of menthol led to high level of TRPM8 activity, with typical P open in excess of 0.5 (Ferná ndez et al., 2011) , see also Figure S3 for sample TRPM8 activity at different membrane potentials). Therefore, simple rejection of traces that, at any point, exhibited multiple conductance levels provided a reliable way to select appropriate traces.
Statistical analyses, t tests, and Gaussian fits to amplitude distributions were carried out using the Microcal Origin software. Values are expressed as mean ± SEM, unless indicated otherwise.
Calcium Microfluorometry
Calcium microfluorometry experiments were performed as described previously (Thebault et al., 2005) . Briefly, the cytosolic Ca 2+ concentration ([Ca 2+ ] i ) was measured using the ratiometric dye Fura-2 and is reported as f/f0. The bath solution was the same one used to record TRPM8 currents.
Immunodetection and Biotynilation
Immunocytochemistry as well as immunoprecipitation, biotinylation, and immunoblotting was performed as described previously (Bavencoffe et al., 2010; Gkika et al., 2010; McKemy et al., 2002; Thebault et al., 2005) . Detailed description is available in the Extended Experimental Procedures.
Confocal Microscopy
Experimental chambers with cells were placed on the stage of Axiovert 200M inverted microscope attached to LSM 510 META laser-scanning unit (Zeiss). The SCSI interface of the confocal microscope was hosted by a Pentium PC (32-bit Windows NT 4.0 operating system) running LSM 510 software (Zeiss).
Confocal imaging was performed as previously described (Bolton and Gordienko, 1998; Gordienko et al., 2008; Povstyan et al., 2011) . Detailed description is available in the Extended Experimental Procedures.
Animals and In Vivo Studies
Two-month-old Wistar rats were obtained from Harlan Laboratories, France. Animals were killed by inhalation of 100% CO 2 , followed by decapitation. These procedures were approved by the local Institutional Animal Care and Use Committee. All experiments were performed on 20-24 g male C57Bl/6J mice (Charles River Laboratories) and TRPM8 -/-mice (kind gift of Prof. D. Julius, UCSF). Animals were acclimatized to the laboratory conditions for at least 1 week prior to testing. They were housed in grouped cages in a temperature-controlled environment with food and water ad libitum. The behavioral experiments were performed blind to the genotype, in a quiet room, by the same experimenter for a given test taking great care to avoid or minimize discomfort of the animals. Treatments were randomized, and all experiments were carried out according to the guidelines of the Committee for Research and Ethical Issues of IASP (Zimmermann, 1983) . Tail immersion test was performed as described earlier (Janssen et al., 1963) . In brief, the water temperature was kept constant at 5 C, 10 C, 15 C, or 20 C ± 0.2 C by using a thermoregulated water bath. Mice were maintained under a soft cloth excepting their tail, which was immersed in the water until withdrawal was observed (cutoff time of 40 s). They were injected subcutaneously (s.c.) with 3 mg/kg morphine, and tail withdrawal latencies were recorded immediately before and 15, 30, 45, 60, and 90 min after treatment. Naloxone-precipitated withdrawal was precipitated as described (Ren et al., 2004) . Briefly, mice were first given twice daily morphine injections (10 mg/kg, s.c.) for 6 days (only one injection at day 6 however) Withdrawal was precipitated on day 6 by injecting naloxone (2 mg/kg, intraperitoneally) 2 hr after the final administration of morphine. Ten minutes before naloxone treatment, mice were placed in a transparent acrylic box (20 cm in diameter, 60 cm high) to habituate to the new environment. Immediately after naloxone challenge, each mouse was placed gently again in the box, and the number of escape jumps (the most characteristic naloxone-precipitated withdrawal withdrawal syndrome by measuring the difference between pain thresholds of mice that have been administered with high-dose morphine regimen, compared to those that received saline, using cold-plate test. Note, that wild-type mice that were treated with morphine exhibited a significantly higher sensitivity to cold exposure than vehicle-treated mice and that this hyperalgesic effect is absent in the TRPM8 À/À animals, n = 5-7 per genotype.
Data are presented as mean ± SEM. **p < 0.01 and ***p < 0.001, respectively. Freshly isolated DRG neurons from Wistar male rats were fixed with 4% formaldehyde-1X PBS for 15 min, washed three times, then permeabilized in PBS-gelatine (Phosphate buffer saline, gelatine 1.2%) complemented with 0.01% Tween 20 and 100mM glycin for 30 min at 37 C. Afterward cells were incubated with primary antibodies: 1/200 goat polyclonal anti-TRPM8 antibody (Antibodies online), 1/50 rabbit polyclonal m-OR antibody (Santa-Cruz) in PBS gelatine at 37 C for 1.5 hr. After thorough washes, the slides were treated with the corresponding secondary antibodies: Rhodamine-Red-X-labeled anti-goat (Jackson ImmunoResearch, dilution: 1/300) and Alexa fluor 488-labeled anti-rabbit (Jackson ImmunoResearch, dilution: 1/250) diluted in PBS-gelatine for 1 hr at room temperature. The slides were then incubated with 0,3% Sudan Black, Reactifs RAL) in 70% ethanol in order to reduce autofluorescence, washed two times and mounted with Mowiol.
Immunoprecipitation, Biotinylation, and Immunoblot Cells were co-transfected with his-tagged hTRPM8pcDNA4 plasmid and my-ORpIREShyg2, washed twice with phosphate buffered saline (PBS) and incubated for 60 min on ice in lysis buffer (Triton X-100 1%, Na deoxycholate, 1%, NaCl 150 mM, PO4NaK 10mM, pH 7,2 and anti-protease cocktail, Sigma, St. Louis, MO, USA). After centrifugation (12000 g for 10 min at 4 C) of the lysates, protein concentration was determined by the BCA assay (Pierce Chemical Company) and equal amount of supernatants were incubated overnight at 4 C with anti-his antibody (Invitrogen) immobilized on protein A/G PLUS agarose beads (Santa Cruz, Biotechnology). After three washes The pellet was washed three times, resuspended in SDS sample buffer and heated at 37 C for 30min, separated on 10% w/v SDS-PAGE gels and analyzed by immunoblotting.
Transfected cells were subjected to cell surface biotinylation and precipitated after lysis with neutravidin-agarose beads (Pierce Rockford, IL, USA) as described in . For the immunoblot analysis we have used rabbit anti-TRPM8 (1/1500, Alomone Labs Ltd, Jerusalem, Israel) and rabbit anti-OPRM1 (1/500, Abcam) antibodies.
Confocal Microscopy
Experimental chambers with cells were placed on the stage of Axiovert 200M inverted microscope attached to LSM 510 META laserscanning unit (Zeiss, Oberkochen, Germany). The SCSi interface of the confocal microscope was hosted by a Pentium PC (32-bit Windows NT 4.0 operating system) running LSM 510 software (Zeiss, Oberkochen, Germany). The imaging was performed using a Zeiss plan-Apochromat 40 3 1.3 N.A. oil-immersion objective with pinhole set to provide a confocal optical slice below 0.8 mm. eYFP fluorescence was excited by the 514 nm line of a 30 mW argon ion laser (Laser-Fertigung, Hamburg, Germany) and was detected at wavelengths 530 -600 nm. The cell plasma membrane was visualized using CellMask Deep Red plasma membrane stain (Invitrogen Ltd.), which was loaded by 5 min incubation of the cells with 2.5 mg/mL of the dye. CellMask Deep Red fluorescence was excited by the 633 nm line of a 15 mW helium/neon ion laser (Laser-Fertigung, Hamburg, Germany) and was detected at wavelengths above 650 nm. In immunostaining experiments primary antibody-specific binding to TRPM8 and OPRM1 was visualized with Alexa Fluor 488-conjugated IgG and Rhodamine-Red-X-conjugated IgG, respectively. Alexa Fluor 488 fluorescence was excited by 488 nm line of Argon lazer and captured at the wavelengths 505-560 nm; Rhodamine Red-X fluorescence was excited by 543 nm of HeNe lazer and captured at the wavelength above 560 nm; DAPI fluorescence was excited by 405 nm line of blue diod lazer and captured at wavelengths 475-505 nm. To avoid any bleed-through of the fluorescence signal the imaging was performed using the frame-byframe multitrack mode of the confocal scanner. The photomultiplier gain and threshold were set to equilibrate the signal intensity at each channel and remove sub-signal noise from the images. The adequacy of the imaging protocol applied to the double-labeled cells was confirmed by control experiments on the mono-labeled cells.
Changes of [Ca 2+ ] i in DRG neurons were imaged using the high-affinity fluorescent Ca 2+ indicators fluo-4 or fluo-3. The former was loaded by 1 hr incubation of the cells with 5 mM fluo-4 acetoxymethyl ester followed by 1 hr wash to allow time for de-esterification. The latter was loaded by dialysis of the cell through the patch pipette with solution supplemented with 100 mM fluo-3 pentapotassium salt (Bolton and Gordienko, 1998) . Confocal [Ca 2+ ] i imaging was performed as described previously (Povstyan et al., 2011) . The x-y confocal images were acquired at 0.6-60 Hz using a Zeiss plan-Apochromat 40 3 1.3 N.A. objective. The fluorescence was excited at 488 nm and was captured at wavelengths above 505 nm. The illumination intensity was attenuated to 0.6% with an acousto-optical tunable filter. In all the experiments the photomultiplier gain was set at 688. To optimize signal quality the pinhole was set to provide a confocal optical section < 4 mm. Studies were carried out on the subset of small diameter DRG neurons that exhibited menthol-induced I TRPM8 with its characteristic biophysical properties (McKemy et al., 2002) . Application of morphine caused a slow reduction of menthol-evoked current in DRG neurons that, within 10 min, led to small but significant decrease of the mean TRPM8 current amplitude at +100 mV (used for the bulk of analysis; see Figures 1A and 1B) as well as À60 mV membrane potentials, as illustrated on this figure. Whole cell recordings (panels A and B) were supplemented by NP open measurements in outside-out patches (panels C and D), comparing menthol-evoked TRPM8 activity to that after morphine addition.
(A) Sample traces of TRPM8 currents invoked by application of 100 mM menthol in DRG neurons at À60 mV holding potential, comparing currents in control cells (white circles) with those where 10 mM morphine was applied at the same time (filled squares). Traces were normalized to their peak amplitudes at the time of menthol application. (B) Bar plot summarizes the responses to menthol in control and morphine treated cells (n = 8 and 6). Statistical analysis was performed for the amplitude of the currents recorded at a time indicated by vertical arrow in (A). (C) Sample activity of TRPM8 in excised outside-out patches. Measurement of basal activity (left) was followed by application of 100 mM menthol (middle), followed by application of 10 mM morphine (indicated by horizontal bar). Assessment of the TRPM8 currents following the morphine treatment was carried out after an extended period of time (typically 10 min) as indicater on the right. (D) Bar plot comparing average activity in outside-out patches in response to menthol and morphine, normalized to basal activity level in each trace (n = 6). * and ** indicate p < 0.05 and 0.01 correspondingly. Data are presented as mean ± s.e.m. HEK293 cells stably expressing TRPM8 proteins under the control of inducible promoter were cultured as described and transfected with OPRM1 receptor plasmid. TRPM8 expression was induced by 1 mg/ml tetracycline for 4.3 hr, until first traces of TRPM8 activity could be observed in cell-attached patches and then recorded for no longer than 30 min, in order to ensure presence of only single channel per patch. Figure shows typical activity in cell-attached patches at different applied potentials, indicated on the left. A characteristic voltage-dependent gating of TRPM8 channel can be observed in these sample traces.
